These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34305396)

  • 1. Design, Synthesis, Characterization and in vivo Antidiabetic Activity Evaluation of Some Chalcone Derivatives.
    Welday Kahssay S; Hailu GS; Taye Desta K
    Drug Des Devel Ther; 2021; 15():3119-3129. PubMed ID: 34305396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes.
    Zhu P; Huang W; Li J; Ma X; Hu M; Wang Y; Xu Q; Wang X
    Chem Biol Drug Des; 2018 Aug; 92(2):1525-1536. PubMed ID: 29704399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines.
    Satyanarayana M; Tiwari P; Tripathi BK; Srivastava AK; Pratap R
    Bioorg Med Chem; 2004 Mar; 12(5):883-9. PubMed ID: 14980600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies.
    Bairagi KM; Younis NS; Emeka PM; Sangtani E; Gonnade RG; Venugopala KN; Alwassil OI; Khalil HE; Nayak SK
    Med Chem; 2020; 16(7):996-1003. PubMed ID: 31880253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of chalcone derivatives as potential anti-diabetic agents.
    Hsieh CT; Hsieh TJ; El-Shazly M; Chuang DW; Tsai YH; Yen CT; Wu SF; Wu YC; Chang FR
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3912-5. PubMed ID: 22608392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antihyperglycemic activity of phenolic C-glycosides.
    Rawat P; Kumar M; Rahuja N; Lal Srivastava DS; Srivastava AK; Maurya R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):228-33. PubMed ID: 21129962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core structure of flavonoids precursor as an antihyperglycemic and antihyperlipidemic agent: an in vivo study in rats.
    Najafian M; Ebrahim-Habibi A; Yaghmaei P; Parivar K; Larijani B
    Acta Biochim Pol; 2010; 57(4):553-60. PubMed ID: 21060897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin.
    Gaur R; Yadav KS; Verma RK; Yadav NP; Bhakuni RS
    Phytomedicine; 2014 Mar; 21(4):415-22. PubMed ID: 24262065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking.
    Konidala SK; Kotra V; Danduga RCSR; Kola PK
    Bioorg Chem; 2020 Nov; 104():104207. PubMed ID: 32947135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
    Rammohan A; Bhaskar BV; Venkateswarlu N; Gu W; Zyryanov GV
    Bioorg Chem; 2020 Jan; 95():103527. PubMed ID: 31911298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of amino moiety enhances the inhibitory potency of 1-tetralone chalcone derivatives against LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages.
    Katila P; Shrestha A; Shrestha A; Shrestha R; Park PH; Lee ES
    Bioorg Chem; 2019 Jun; 87():495-505. PubMed ID: 30927590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice.
    Zheng J; He J; Ji B; Li Y; Zhang X
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():427-31. PubMed ID: 17392144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and DFT Calculations of Novel Vanillin-Chalcones and Their 3-Aryl-5-(4-(2-(dimethylamino)-ethoxy)-3-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbaldehyde Derivatives as Antifungal Agents.
    Illicachi LA; Montalvo-Acosta JJ; Insuasty A; Quiroga J; Abonia R; Sortino M; Zacchino S; Insuasty B
    Molecules; 2017 Sep; 22(9):. PubMed ID: 29240047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats.
    Ahmadi A; Khalili M; Farsadrooh M; Ghiasi M; Nahri-Niknafs B
    Drug Res (Stuttg); 2013 Dec; 63(12):614-9. PubMed ID: 23828271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of 1,4-Dihydropyridine-Indole as a Potential Antidiabetic Agent via GLUT4 Translocation Stimulation.
    Katiyar S; Ahmad S; Kumar A; Ansari A; Bisen AC; Ahmad I; Gulzar F; Bhatta RS; Tamrakar AK; Sashidhara KV
    J Med Chem; 2024 Jul; 67(14):11957-11974. PubMed ID: 39013034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacognostical standardization and antidiabetic activity of Syzygium cumini (Linn.) barks (Myrtaceae) on streptozotocin-induced diabetic rats.
    Tripathi AK; Kohli S
    J Complement Integr Med; 2014 Jun; 11(2):71-81. PubMed ID: 24760764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
    Singh FV; Chaurasia S; Joshi MD; Srivastava AK; Goel A
    Bioorg Med Chem Lett; 2007 May; 17(9):2425-9. PubMed ID: 17336063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of luteolin 5-O-beta-rutinoside in streptozotocin-induced diabetic rats.
    Zarzuelo A; Jiménez I; Gámez MJ; Utrilla P; Fernadez I; Torres MI; Osuna I
    Life Sci; 1996; 58(25):2311-6. PubMed ID: 8649220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats.
    Cemek M; Kağa S; Simşek N; Büyükokuroğlu ME; Konuk M
    J Nat Med; 2008 Jul; 62(3):284-93. PubMed ID: 18404309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the antibacterial and antifungal activities of synthetic benzyl bromides, ketones, and corresponding chalcone derivatives.
    Shakhatreh MA; Al-Smadi ML; Khabour OF; Shuaibu FA; Hussein EI; Alzoubi KH
    Drug Des Devel Ther; 2016; 10():3653-3660. PubMed ID: 27877017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.